TSH Biopharm Submits New Drug Application to Taiwan FDA Seeking Approval of RNTA06 for the Treatment of Angina
2019.8.30
TSH Biopharm Submits New Drug Application to Taiwan FDA Seeking Approval of RNTA06 for the Treatment of Angina
TSH Biopharm’s (8432) new entity new drug, RNTA06 has completed first Asian people clinical study and today announced its New Drug Application (NDA) were accepted by the Taiwan Food and Drug Administration (TFDA)… View more
